Report Overview

The Antibiotics market size in Kenya stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Antibiotics also known as an Antibacterial agent, are drugs that have the ability to destroy or slow down the growth of bacteria and are widely used for the treatment and prevention of diseases like Tuberculosis, Pneumonia, Diarrhoea, Malaria and Sexually Transmitted Diseases that are highly prevalent in Kenya. Broad Spectrum Antibiotics are effective against both Gram-positive and Gram-negative bacteria as well as certain protozoan infections.



Market Drivers

The demand for antibiotics is significantly increasing owing to the huge burden of infectious diseases in Kenya. The high prevalence of infectious diseases, such as lower respiratory infections, pneumonia, malaria, and tuberculosis, is expected to fuel the market growth.

In 2019, the Kenya national malaria incidence was reported at 125.92 cases per 1000 population. According to a study conducted in 2020, the prevalence of diarrhoea among children under five years in the households of urban informal settlements in Kenya was 18.7%.

The rising prevalence of bacterial infections, coupled with the need for effective and newer antibiotics, is driving the demand for advanced antibiotics

However, large number of counterfeit drugs in the market and anti-microbial resistance due to antibiotics are restraining growth of antibiotics market in Kenya.